IN SILICO INTERACTION STUDIES OF RESVERATROL AND SILIBININ WITH DIFFERENT PROTEIN TARGETS USING MOLECULAR DOCKING

J. Venkatesh Yadav; G. V. Sudhakar Rao; N. Pazhanivel; P.L. Sujatha

doi:10.56093/ijvasr.v53i2.152724

Authors

J. Venkatesh Yadav Ph.D. Scholar, Department of Veterinary Pathology, Madras Veterinary College, TANUVAS, Chennai – 600 007
G. V. Sudhakar Rao Professor and Head, Department of Veterinary Pathology, Madras Veterinary College, TANUVAS, Chennai – 600 007
N. Pazhanivel Professor, Department of Veterinary Pathology, Madras Veterinary College, TANUVAS, Chennai – 600 007
P.L. Sujatha University Deputy Librarian, Madras Veterinary College, Chennai – 600 007

https://doi.org/10.56093/ijvasr.v53i2.152724

Keywords:

Resveratrol, Silibinin, in silico

Abstract

Resveratrol and silibinin are natural phytochemicals with considerable anticancer properties. They induce apoptosis of cancer cells by binding to various protein targets. Hence in this study, in silico molecular interaction studies were made between ligand resveratrol and ligand silibinin with NF-kB p50 subunit and p65 subunit, MMP9, caspase 3 and Bax proteins. The in silico molecular interaction revealed that silibinin and resveratrol interacted with five receptors with a high binding affinity and docking score making them novel inhibitors against various types of diseases.

Downloads

Download data is not yet available.

References

Adetuyi, B.O., Omolabi, F.K., Olajide, P.A. and Oloke, J.K. (2021). Pharmacological, biochemical and therapeutic potential of milk thistle (silymarin): a review. World News of Natural Sciences, 37: 75 - 91.

Berman, A.Y., Motechin, R.A., Wiesenfeld, M.Y. and Holz, M.K. (2017). The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precision Oncology, 1(1): 1 - 9.

Daina, A., Michielin, O. and Zoete, V. (2017). Swiss ADME: a free web tool to evaluate pharmacokinetics, drug likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7: 42717.

Mulakayala, C., Babajan, B., Madhusudana, P., Anuradha, C.M., Rao, R.M., Nune, R.P. and Kumar, C.S. (2013). Synthesis and evaluation of resveratrol derivatives as new chemical entities for cancer. Journal of Molecular Graphics and Modelling, 41: 43 - 54.

Nishikori, M. (2005). Classical and alternative NF-KB activation pathways and their roles in lymphoid malignancies. Journal of Clinical and Experimental Hematopathology, 45(1): 15 - 24.

Safdari, Y., Khalili, M., Ebrahimzadeh, M.A., Yazdani, Y. and Farajnia, S. (2015). Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action. Pharmacological Research, 93: 1 -10.